On February 19, the State Administration of Markets (of China) issued a notice revoking the title of China Quality Award that the China Tong Ren Tang (Group) Company had previously received. The notice, that the General Administration of Market Supervision issued, revealed that the award was revoked because Tong Ren Tang’s subsidiary used expired honey for production and was suspected of changing the date of production.”
Tong Ren Tang is a household brand name in Chinese medicine in Beijing, with over a hundred years of history. The Tong Ren Tang (Group) has six secondary groups, three institutes, and five directly affiliated subsidiaries. It has won the China Quality Award and the Beijing Municipal Government Quality Management Award. By the end of 2017, it had more than 2,600 kinds of products in six major categories, such as medicine and health foods, 36 production bases, 105 modern production lines, and a national engineering center. The group system has a total of 2,121 retail terminals and 488 medical service terminals.
As the company expanded, it was also frequently found to have breached quality control. At the end of 2018, the State Food and Drug Administration issued a statement that 63 batches of licorice (licorice tablets) that Beijing Tong Ren Tang and other enterprises produced did not meet qualifications. In 2017 alone, due to a number of quality problems, Tong Ren Tang’s subsidiaries were “blacklisted” 10 times.
Source: 163.com, February 20, 2019